Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH website changes and says “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T19:32:20.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T22:07:33.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:01:15.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page previously displaying a study record now shows a 403 Forbidden error, with site chrome (navigation/footer) still visible, indicating the content is temporarily inaccessible.
    Difference
    19%
    Check dated 2026-09-19T19:18:15.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A new NIH grant/contract identifier was added to the study's identifiers, and the page revision was updated to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:39:54.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, reflecting a minor platform update rather than changes to user-facing content.
    Difference
    0.0%
    Check dated 2026-08-08T14:49:37.000Z thumbnail image

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.